ADD methods to aim 2b

This commit is contained in:
Nathan Dwarshuis 2021-07-28 17:03:54 -04:00
parent 3238963b77
commit b3558707d0
1 changed files with 65 additions and 1 deletions

View File

@ -53,6 +53,8 @@
\newacronym{pdms}{PDMS}{polydimethylsiloxane} \newacronym{pdms}{PDMS}{polydimethylsiloxane}
\newacronym{dc}{DC}{dendritic cell} \newacronym{dc}{DC}{dendritic cell}
\newacronym{il2}{IL2}{interleukin 2} \newacronym{il2}{IL2}{interleukin 2}
\newacronym{il15}{IL15}{interleukin 15}
\newacronym{il15r}{IL15R}{interleukin 15 receptor}
\newacronym{rhil2}{rhIL2}{recombinant human interleukin 2} \newacronym{rhil2}{rhIL2}{recombinant human interleukin 2}
\newacronym{apc}{APC}{antigen presenting cell} \newacronym{apc}{APC}{antigen presenting cell}
\newacronym{mhc}{MHC}{major histocompatibility complex} \newacronym{mhc}{MHC}{major histocompatibility complex}
@ -104,7 +106,11 @@
\newacronym{fcs}{FCS}{flow cytometry standard} \newacronym{fcs}{FCS}{flow cytometry standard}
\newacronym{ivis}{ivis}{in vivo imaging system} \newacronym{ivis}{ivis}{in vivo imaging system}
\newacronym{iacuc}{IACUC}{institutional animal care and use committee} \newacronym{iacuc}{IACUC}{institutional animal care and use committee}
\newacronym{hbss}{HBSS}{Hank's buffered saline solution}
\newacronym{leaf}{LEAF}{low endotoxin, azide-free}
\newacronym{cytof}{CyTOF}{cytometry time-of-flight}
\newacronym{spade}{SPADE}{spanning-tree progression analysis of
density-normalized events}
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% SI units for uber nerds % SI units for uber nerds
@ -2076,6 +2082,64 @@ provide these benefits.
\section{introduction} \section{introduction}
\section{methods} \section{methods}
\subsection{collagenase digestion}
% TODO The concentration for the surface marker cleavage experiment was much
% higher, if that matters
\glspl{dms} were digested in active T cell cultures via addition of sterile
\product{\gls{colb}}{Sigma}{11088807001} or
\product{\gls{cold}}{Sigma}{11088858001}. Collagenase was dissolved in
\product{\gls{hbss}}{Gibco}{14025-076} or
\product{TexMACS}{\miltenyi}{170-076-307} at approximately \SI{100}{\ug\per\ml}.
This solution was added to T cell cultures at a 1:1 ratio in place of plain
media normally used to feed the cells during the regular media addition cycle at
day 4. Cultures were then incubated as described in \cref{sec:tcellculture}, and
the \glspl{dms} were verified to have been digested after \SI{24}{\hour}.
\subsection{mass cytometry and clustering analysis}
T cells were stained using a \product{34 \gls{cytof} marker
panel}{Fluidigm}{201322} and \product{cisplatin}{Fluidigm}{201064} which were
used according to the manufacturers instructions. \numrange{2e6}{3e6} stained
cells per group were analyzed on a Fluidigm Helios.
% FIGURE add the spade gating diagram from the paper
Unbiased cell clusters were obtained using \gls{spade} analysis by pooling three
representative \gls{fcs} files and running the \gls{spade} pipeline with k-means
clustering (k = 100), arcsinh transformation with cofactor 5, density
calculation neighborhood size of 5 and local density approximation factor of
1.5, target density of 20000 cells, and outlier density cutoff of
\SI{1}{\percent}. All markers in the \gls{cytof} panel were used in the analysis
\subsection{integrin blocking experiments}
To block \gls{a2b1} and \gls{a2b2}, active T cell cultures with \gls{dms} were
supplemented with \product{\anti{\gls{a2b1}}}{Sigma}{MAB1973Z} and
\product{\anti{\gls{a2b2}}}{Sigma}{MAB1950Z} (both \gls{leaf}) at indicated
concentrations and timepoints. T cells were grown as described in
\cref{sec:tcellculture}.
\gls{a2b1} and \gls{a2b2} were verified to be present on active T cell cultures
by staining with \product{\anti{\gls{a2b1}}-\gls{apc}}{\bl}{328313} and
\product{\anti{\gls{a2b2}}-\gls{fitc}}{\bl}{359305} on day 6 of culture and
analyzing via a BD Accuri flow cytometer.
\subsection{IL15 blocking experiments}
To block the \gls{il15r}, we supplemented T cell
cultures activated with \gls{dms} with either
\product{\anti{\gls{il15r}}}{Rnd}{AF247} or \product{\gls{igg} isotype
control}{RnD}{AB-108-C} at the indicated timepoints and concentrations. T
cells were grown as otherwise described in \cref{sec:tcellculture} with the
exception that volumes were split by $\frac{1}{3}$ to keep the culture volume
constant and minimize the amount of \gls{mab} required.
To block soluble \gls{il15}, we supplemented analogously with
\product{\anti{\gls{il15}}}{RnD}{EEP0419081} or \product{\gls{igg} isotype
control}{\bl}{B236633}.
\section{results} \section{results}
\subsection{adding or removing DMSs alters expansion and phenotype} \subsection{adding or removing DMSs alters expansion and phenotype}